Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis Volume 11, 2010 - Issue 5
Journal homepage
659
Views
88
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

A randomized, placebo-controlled trial of memantine for functional disability in amyotrophic lateral sclerosis

Mamede de Carvalho Neuroscience Department, Hospital de Santa Maria-Centro Hospitalar Lisboa Norte, Lisbon; Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon, Lisbon, PortugalCorrespondence[email protected]
,
Susana Pinto Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon, Lisbon, Portugal
,
João Costa Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon, Lisbon, Portugal
,
Teresinha Evangelista Neuroscience Department, Hospital de Santa Maria-Centro Hospitalar Lisboa Norte, Lisbon; Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon, Lisbon, Portugal
,
Bemjamim Ohana Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon, Lisbon, Portugal
&
Anabela Pinto Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon, Lisbon, Portugal
Pages 456-460 | Received 24 Apr 2010, Accepted 31 May 2010, Published online: 22 Jun 2010

References

  • van Damme P, Dewil M, Robberecht W, van den Bosh L. Excitoxicity in amyotrophic lateral sclerosis. Neurodegener Dis. 2005;2:147–59.
  • Wang R, Zhang D. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model. Eur J Neurosc. 2005;22:2376–80.
  • Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose ranging study of riluzole in amyotrophic lateral sclerosis. Lancet. 1996;347:1425–31.
  • Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I. Memantine treatment in patients with moderate to severe Alzheimer's disease already receiving donepezil: a randomized controlled trial. JAMA. 2004;291: 317–24.
  • Parsons CG, Stoffler A, Danysz W. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system – too little activation is bad, too much is even worse. Neuropharmacol. 2007;53:699–723.
  • Joo IS, Hwang DH, Seok JI, Shin SK, Kim SU. Oral administration of memantine prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis. J Clin Neurol. 2007;3:181–6.
  • Brooks BR, Miller RG, Swash M, Munsat TL, for the World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2000;1:93–300.
  • Cedarbaum JM, Stambler N. Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicentre clinical trials. J Neurol Sci. 1997;152(Suppl 1):1–8.
  • de Carvalho M, Swash M. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis? Arch Neurol. 2006;63:558–62.
  • de Carvalho M, Swash M. Quantitating progression in ALS. Neurology. 2005;64:1783–5.
  • Remy AJ, Camu W, Ramos J, Blanc P, Larrey D. Acute hepatitis after riluzole administration. J Hepatol. 1999;30:527–30.
  • de Carvalho M, Chio A, Dengler R, Hecht M, Weber M, Swash M. Neurophysiological measures in amyotrophic lateral sclerosis: markers of progression in clinical trials. Amyotroph Lateral Scler. 2005;6:17–28.
  • Doble A. The pharmacology and mechanism of action of riluzole. Neurology. 1996;47:S233–41.
  • de Carvalho M, Costa J, Swash M. Clinical trials in ALS: a review of the role of clinical and neurophysiological measurements. Amyotroph Lateral Scler. 2005;6:202–12.
  • Cudkowicz ME, Shefner JM, Schoenfeld DA, Brown RH, Johnson H, Quareshi M, . A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology. 2003;61:456–64.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.